Wang Yongyan

 Academician Wang Yongyan, a Han National, was born in September, 1938 in Tianjin. He is a graduate of the Department of Medicine at Beijing Institute of Traditional Chinese Medicine. He is a representative of the standing committee of the National People's Congress, a renowned TCM expert, an academician at the Chinese Academy of Engineering, president of Yunnan Medicine Research Institute, honorary director of the Degree and Education Guidance Committee of the College of Resources Science & Technology at BNU, director of the Institute of Resources Drugs and Traditional Chinese Medicine Resources, and a doctoral supervisor. He has successively served as President of the Beijing University of Chinese Medicine, President and Honorary President of the China Academy of Chinese Medical Sciences, President of the Beijing Institute of Acupuncture and Moxibustion Clinics, editor of the China Science and the Chinese Science Bulletin, and convener of the Appraisal Group of the Chinese Medicine Discipline, which is supported by the State Council Academic Degrees Committee. Engaged in the practice, research and teaching of TCM for over thirty years, Wang has as his research focus stroke and diseases of the brain.

Wang has undertaken key projects involving TCM prevention and the treatment of stroke and senile dementia, as supported by the national Seventh, Eighth, and Ninth Five-Year plans program, eight projects supported by the National Education Committee’s doctoral stations (in 1990) (in 1996) and the National New Medicine Development Fund, and “TCM Cerebral Vascular Rehabilitation,” a research program in cooperation with the World Health Organization. He is also one of the main developers of Qing Kai Ling, an intravenous injection therapy that enhances medical effects and moderates invalidity and is an essential drug in the treatment of acute diseases.

Based on his clinical research and examination of ischemic stroke systems, Wang summarizes the rules for the evolution of the syndrome, as well as its treatment and cure. To deal with the syndromes of phlegm in its acute phase and phlegm bowel evidence, he designed and created phlegm-reducing Catharsis Soup and Qing Kai Ling.

He participated in drafting the evaluation Standard for TCM diagnosis and treatment for stroke, which is now in trials. The Standard is involved in the first application of the scoring of metrology to evaluate curative effects and employs differentiation profiling and CT and MRI scanning, along with clinical epidemiology and other methodologies to deepen the research, and so plays an important role in proving the scientific nature of the value of TCM as a clinical discipline.

In terms of research on TCM academic and management standards, Wang participated in and presided over the Standard Record of TCM Cases, which was implemented after revision. Currently he is chief scientist, as named by the Ministry of Science and Technology, undertaking National Key Basic Research Development and Planning Project 973, namely, “Basic Research on the Key Scientific Problems of Prescription.” He is also in charge of many major national projects related to and impacting on the progress of the TCM practice and the development of TCM disciplines.

Since 1986 Wang has been awarded the National Science and Technology Progress Award one time and third prize three times, and twice has been awarded first prize by the Department and Municipal Levels and third prize three times. In 1998 he won the Science and Technology Progress Prize Award supported by The Ho Leung Ho Lee Foundation and the Outstanding Works Award of Lifu Chinese Medicine. He has edited 12 academic monographs and published more than 80 academic papers.

Copyright © 2011 Beijing Normal University. All rights Beijing Normal University No. 19, XinJieKouWai St., HaiDian District, Beijing 100875, P. R. China
BNU telephone directory assistance: 010-58806183 One-stop logistics service hotline: 010-58801111